Oncology · Phase III

Top sponsors

• AstraZeneca 75 programs
• Chinese Academy of 70 programs
• HOFFMANN-LA ROCHE 68 programs
• MSD Merck Sharp 56 programs
• First People's Hospital 53 programs
• Ningbo Cancer Hospital 44 programs
• United Therapeutics Europe 43 programs
• Anaxis Pharma 37 programs
• AstraZeneca 37 programs
• Novartis India 32 programs
• George Institute for 29 programs
• Takeda 28 programs

1. Nimotuzumab

   Praxis Precision Medicines

   Pancreatic Cancer, Advanced or Metastatic

   phase 3 · small molecule · completed

   1 trial →

2. Nimotuzumab

   The First People's Hospital of Lianyungang

   Nasopharyngeal Carcinoma

   phase 3 · small molecule · active

   1 trial →

3. Niraparib

   GlaxoSmithKline

   Neoplasms, Breast

   phase 3 · small molecule · active

   1 trial →

4. Niraparib Placebo Tablets

   GlaxoSmithKline

   Neoplasms, Breast

   phase 3 · small molecule · active

   1 trial →

5. Niraparib tosylate monohydrate + abiraterone... for Prostate Cancer

   The George Institute

   Prostate Cancer

   phase 3 · small molecule · active

   1 trial →

6. Nivolumab

   Bristol-Myers Squibb

   Bladder Cancer

   phase 3 · mab · completed

   1 trial →

7. Nivolumab

   Bristol-Myers Squibb

   Head and Neck Cancer

   phase 3 · mab · completed

   1 trial →

8. Nivolumab

   Ono Pharmaceutical Co.,

   Gastric Cancer

   phase 3 · small molecule · completed

   1 trial →

9. Nivolumab

   Bristol-Myers Squibb

   Colorectal Cancer

   phase 3 · mab · completed

   1 trial →

10. Nivolumab

    Shanghai Reinovax Biologics Co.,LTD

    Metastatic Kidney Cancer

    phase 3 · small molecule · active

    1 trial →

11. Nivolumab

    Bristol-Myers Squibb

    Brain Neoplasms

    phase 3 · small molecule · completed

    1 trial →

12. Nivolumab

    Bristol-Myers Squibb

    Gastric Cancer

    phase 3 · small molecule · completed

    1 trial →

13. Nivolumab

    Nektar Therapeutics UK Limited

    Bladder Cancer

    phase 3 · mab · completed

    1 trial →

14. OBI-822-011

    Lacuna Pharma Pty Ltd

    Triple Negative Breast Cancer

    phase 3 · small molecule · active

    1 trial →

15. OLAPARIB

    AstraZeneca

    Platinum Sensitive Relapsed Ovarian Cancer

    phase 3 · small molecule · terminated

    1 trial →

16. ONO-4059-17

    Lacuna Pharma Pty Ltd

    Relapsed/refractory primary central nervous system lymphoma

    phase 3 · small molecule · active

    1 trial →

17. OP-1250-301

    Olema Pharmaceuticals

    ER+, HER2- metastatic breast cancer following endocrine and CDK 4/6 inhibitor therapy

    phase 3 · small molecule · active

    1 trial →

18. OP-1250-302

    Olema Pharmaceuticals

    ER+, HER2- Advanced Breast Cancer

    phase 3 · small molecule · active

    1 trial →

19. OPDIVO 10 mg/mL concentrate for solution for infusion.

    Disc Medicine

    oesophageal cancer

    phase 3 · small molecule · active

    1 trial →

20. OT-101

    Oncotelic Therapeutics

    Pancreatic Ductal Adenocarcinoma

    phase 3 · small molecule · active

    1 trial →

21. Obatoclax Mesylate, Carboplatine and Etoposide

    Teva Pharma GmbH

    Extensive-stage Small Cell Lung Cancer

    phase 3 · small molecule · terminated

    1 trial →

22. Obinutuzumab

    TG THERAPEUTICS, INC.

    Chronic Lymphocytic Leukemia

    phase 3 · mab · terminated

    1 trial →

23. Obinutuzumab

    United Therapeutics Europe Ltd

    Non-Hodgkin's Lymphoma

    phase 3 · small molecule · completed

    1 trial →

24. Odronextamab

    ADC Therapeutics SA

    B-cell Non Hodgkin Lymphoma

    phase 3 · small molecule · active

    1 trial →

25. Odronextamab

    Regeneron UK Limited

    Relapsed/Refractory Follicular Lymphoma

    phase 3 · small molecule · active

    1 trial →

26. Odronextamab

    Regeneron UK Limited

    Diffuse Large B-cell Lymphoma (DLBCL)

    phase 3 · small molecule · active

    1 trial →

27. Odronextamab

    Regeneron UK Limited

    Follicular Lymphoma (FL)

    phase 3 · small molecule · active

    2 trials →

28. Olaparib

    AstraZeneca

    Breast Cancer Metastatic

    phase 3 · small molecule · completed

    1 trial →

29. Olaparib 300mg tablets

    AstraZeneca

    Relapsed Ovarian Cancer

    phase 3 · small molecule · completed

    1 trial →

30. Oral immunonutrition

    Hospital Authority, Hong Kong

    Non Small Cell Lung Cancer

    phase 3 · other · active

    1 trial →

31. Orteronel

    Takeda

    Prostate Cancer

    phase 3 · small molecule · completed

    3 trials →

32. Osimertinib

    AstraZeneca

    Cancer

    phase 3 · small molecule · active

    1 trial →

33. Osimertinib

    The First People's Hospital of Lianyungang

    Non-small Cell Carcinoma

    phase 3 · small molecule · active

    1 trial →

34. Oxaliplatin

    The First People's Hospital of Lianyungang

    Rectal Cancer

    phase 3 · small molecule · active

    1 trial →

35. Oxaliplatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rectal Neoplasms

    phase 3 · small molecule · active

    1 trial →

36. Oxybutynin Chloride

    United Therapeutics Europe Ltd

    Breast Carcinoma

    phase 3 · small molecule · completed

    1 trial →

37. P.64Cu.003.01

    A.C.O.M. - Advanced Center Oncology

    Prostate cancer at risk of developing metastatic lesions

    phase 3 · small molecule · active

    1 trial →

38. PACIFIC2/D933KC00001

    AstraZeneca AB

    Patients with Locally Advanced, Unresectable Non-small Cell Lung Cancer (Stage III)

    phase 3 · small molecule · active

    1 trial →

39. PBP-301

    Lacuna Pharma Pty Ltd

    Metastatic castration-resistant prostate cancer (mCRPC)

    phase 3 · small molecule · active

    1 trial →

40. PD-0332991

    Pfizer

    Breast Neoplasms

    phase 3 · small molecule · completed

    1 trial →

41. PEAK-1

    Arcus Biosciences

    Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma

    phase 3 · small molecule · active

    1 trial →

42. PEMBROLIZUMAB

    Ningbo Cancer Hospital

    Squamous cell carcinoma of head and neck

    phase 3 · small molecule · active

    1 trial →

43. PEMBROLIZUMAB

    Ningbo Cancer Hospital

    Patient with early triple-negative breast cancer (TNBC) achieving pathologic complete response (pCR) after neoadjuvant systemic chemotherapy and pembrolizumab.

    phase 3 · small molecule · active

    1 trial →

44. PEMBROLIZUMAB , BNT113

    BioNTech SE

    Unresectable head and neck squamous cell carcinoma, metastatic head and neck cancer, recurrent head and neck cancer

    phase 3 · small molecule · active

    1 trial →

45. PF-02341066

    Pfizer

    Carcinoma, Non-Small-Cell Lung

    phase 3 · small molecule · completed

    2 trials →

46. PF-05280014

    Pfizer

    Metastatic Breast Cancer

    phase 3 · mab · completed

    1 trial →

47. PF-05280586

    Pfizer

    Follicular Lymphoma

    phase 3 · mab · completed

    1 trial →

48. PF-06801591

    Pfizer

    Non-muscle Invasive Bladder Cancer

    phase 3 · small molecule · active

    1 trial →

Frequently asked questions